OIS@ASCRS
Paul McLean, ClarVista Medical’s CEO, stressed the importance of rotational stability as he extolled the benefits of the company’s Harmoni Modular Intraocular Lens (IOL). The…
Read More
Mark Packer, MD, chief medical officer at Cassini, told OIS@ASCRS the cornea measurement company is moving into the diagnosis of dry eye disease. The firm…
Read More
Reza Zadno, president and CEO of Avedro, told OIS@ASCRS attendees that the company’s corneal remodeling technology could reach a huge untapped market of people who…
Read More
Yari Mitchell, VP, Global Medical Affairs & Business Strategy, delivered a commercial overview and laid out some of the changes AcuFocus has made to its…
Read More
Tom Mitro, chief operating officer of Aerie Pharmaceuticals, brought the OIS@ASCRS community up-to-date on the clinical progress for Rhopressa and Roclatan. The company is entering…
Read More
Conceived just a few years ago by a team of students at the Stanford Biodesign program, Oculeve’s TrueTear device is positioned to provide desperately needed…
Read MoreOIS Co-Chair Bill Link of Versant Ventures welcomes attendees to OIS@ASCRS 2016 with a history of how the Ophthalmology Innovation Summits started, where they’re headed…
Read More
By Michael Lachman The cataract surgery premium channel consists primarily of presbyopia-correcting intraocular lenses (PC-IOLs), toric IOLs that correct astigmatism, and femtosecond-laser assisted cataract surgery…
Read More
Just about two weeks after getting Food and Drug Administration (FDA) clearance for its corneal crosslinking platform, Avedro Chief Medical Officer Rajesh K. Raipal, MD,…
Read More
Robert Dempsey, Vice President and Business Unit Head of Ophthalmology, Shire. See below for the Video Timestamp: 00:30 – How do you build a brand…
Read More
Michael Onuscheck, global surgical franchise head for Alcon, a Novartis company, outlined the firm’s approach to innovation within the premium channel, which involves both internal…
Read More
Over the past year, Abbott Medical Optics (AMO) has established a leading share position in the US PC-IOL market, driven by the new low-add-power Tecnis…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")